Researchers from Columbia University in New York have created a universal antiviral treatment that works in the same way as ISG15 immunodeficiency, a rare condition that exposes people to certain bacterial illnesses but grants immunity against all viruses.
Scientists have managed to stimulate the production of the 10 most beneficial proteins produced by the immunodeficiency mutation, with the potential to create an all-encompassing antiviral treatment.
The treatment could be made available to first responders and high-risk individuals in the event of future pandemics, before targeted vaccines are developed.
Human trials are yet to take place, but the treatment has been administered to hamsters and mice with promising results via an intranasal vaccine.
Commenters on the popular tech website Hackaday are divided in their view of the treatment, which one commenter describes as “experimental snake juice”, while others urge people to get vaccinated in the interests of public health.
